Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system

Regulatory Peptides

Volumn 78, Issue 1-3, 1998, Pages 13-18

  Ferrario, Carlos M ^a   Iyer, Shridhar N ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin peptides; Angiotensin receptors; Blood pressure; Hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II DERIVATIVE; PEPTIDE;

ANTIHYPERTENSIVE ACTIVITY; HUMAN; HYPERTENSION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032583129     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00134-7     Document Type: Review

References (67)

1. [1] Menard J. Anthology of the renin-angiotensin system: A one hundred reference approach to angiotensin II antagonists. J Hypertens 1993;11:S3-S11.
2. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a Kinin-dependent mechanism. Hypertension 1998;31:349-55.
3. [3] Nasjletti A. The role of eiconsanoids in angiotensin-dependent hypertension. Hypertension 1998;31:194-200.
4. [4] Scicli AG, Carretero OA. Renal kallikrein-kinin system. Kidney Int 1986;29:120-30.
5. [5] Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-41.
6. [6] Jessell TM, Womack MD. Substance P and the novel mammalian tachykinins: a diversity of receptors and cellular actions. Trends Neurol Sci 1985;2:43-5.
7. [7] Chappell MC, Iyer SN, Diz DI, Ferrario CM. Antihypertensive effects of angiotensin-(1-7). Braz J Med Biol Res 1998; 31, in press
8. [8] Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997;30:535-41.
9. [9] Britto RR, Santos RAS, Fagundes-Moura CR, Khosla MC, Campangnole-Santos MJ. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension 1997;30:549-56.
10. [10] Paula RD, Lima CV, Khosla MC, Santos RAS. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995;26:1154-9.
11. [11] Carey RM, Vaughan Jr. ED, Peach MJ, Ayers CR. Activity of [des-aspartyl 1] angiotensin II and angiotensin II in man - differences in blood pressure and adrenocortical responses during normal and low sodium intake. J Clin Invest 1978;61:20-31.
12. [12] Harding JW, Wright JW, Swanson GN, Hanesworth JM, Krebs LT. AT4 receptors: specificity and distribution. Kidney Int 1994;46:1510-2.
13. [13] Tan F, Morris PW, Skidgel RA, Erdos EG. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem 1993;268:16631-8.
14. [14] Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties, and enzymatic activity of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 1993;52:1461-80.
15. [15] Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endothelins by neutral endopeptidase 24,11 (enkephalinase). J Biol Chem 1990;265:14150-5.
16. [16] Carretero OA, Scicli AG. Zinc metallopeptidase inhibitors. Hypertension 1991;68:366-71.
17. 2 receptors in the plasma clearance of angiotensin II. J Cardiovasc Pharmacol 1998;31:464-9.
18. [18] Vernace MA, Mento PF, Maita ME, Wilkes BM. Effects of angiotensin receptor subtype inhibitors on plasma angiotensin clearance. Hypertension 1994;23:853-6.
19. [19] Ferrario CM. Biological roles of angiotensin-(1-7). Hypertens Res 1992;15:61-6.
20. [20] Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension 1998;31:362-7.
21. [21] Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997;29:394-400.
22. [22] Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM. Converting enzyme determines the plasma clearance of angiotensin-(1-7). Hypertension 1998;32:496-502.
23. 1-7 and Keto-ACE (abstract). Hypertension 1997;30:494.
24. [24] Ng KKF, Vane JR. Conversion of angiotensin I to angiotensin II. Nature 1967;216:762-6.
25. [25] Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
26. [26] Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens 1996;14:799-805.
27. [27] Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides 1993;14:883-91.
28. [28] Campbell DJ, Duncan AM, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive donryu rats. Hypertension 1995;25:928-34.
29. [29] Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides 1993;14:679-84.
30. 9) BK: influence of enalaprilat. Am J Physiol 1996;270:H1340-7.
31. [31] Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561-75.
32. [32] Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 1989;3:31-6.
33. [33] Santos RAS, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, et al. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension (SupplI) 1988;11:153-7.
34. [34] Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptides. J Biol Chem 1989;264:16518-23.
35. [35] Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma × glioma hybrid cell line. Peptides 1990;11:375-80.
36. [36] Chappell MC, Jaiswal N, Brosnihan KB, Ferrario CM. Processing of angiotensin I to angiotensin-(1-7) by vascular smooth muscle cells of spontaneously hypertensive rats (abstract). Hypertension 1991;18:385-6.
37. [37] Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992;19:692-6.
38. [38] Deddish PA, Marcic B, Jackman HL, Wang H-Z, Skidgel RA, Erdos EG. N-domain specific substrate and C-domain inhibitors of angiotensin converting enzyme. Hypertension 1998;31:912-7.
39. [39] Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 1988;85:4095-8.
40. [40] Benter I, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995;269:H313-9.
41. [41] DelliPizzi A, Hilchey SD, Bell-Quilley CP. Natriuretic actions of angiotensin-(1-7). Br J Pharmacol 1994;111:1-3.
42. [42] Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7) in vivo and in vitro studies. Am J Physiol 1996;270:F141-7.
43. [43] Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998;31:699-705.
44. [44] Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 1998;31:356-61.
45. [45] Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, et al. Opposing actions of Angiotensin-(1-7) and Angiotensin II in the brain of transgenic hypertensive rats. Hypertension 1995;25:1260-5.
46. [46] Ferrario CM, Martell N, Yunis C, Flack JM, Chappell MC, Brosnihan KB, et al. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens 1998;11:137-46.
47. [47] Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH. Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis. Hypertension 1990;16:555-63.
48. [48] Santos RAS, Silva ACS, Magaldi AJ, Khosla MC, Ceasr KR, Passaglio KT, et al. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension 1996;27:875-84.
49. [49] Mahon JM, Allen M, Herbert J, Fitzsimons JT. The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol. Neurosci Lett 1995;69:199-208.
50. [50] Campagnole-Santos MJ, Heringer SB, Batista EN, Khosla MC, Santos RAS. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol 1992;263:R89-94.
51. [51] Campagnole-Santos MJ, Diz DI, Santos RAS, Khosla MC, Brosnihan KB, Ferrario CM. Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol 1989;257:H324-9.
52. [52] Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension (SupplII) 1992; 19:49-55.
53. [53] Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: Subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 1993;265:664-73.
54. [54] Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension 1993;21:900-5.
55. [55] Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 1993;234:35-42.
56. [56] Abbas A, Gorelik G, Carbini LA, Scicli AG. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension 1997;30:217-21.
57. [57] Lima CV, Paula RD, Resende FL, Khosla MC, Santos RAS. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 1997;30:542-8.
58. [58] Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 1994;111:652-4.
59. [59] Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke 1993;24:2041-5.
60. [60] Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(I-7) in spontaneously hypertensive rats. Am J Physiol 1995;269:H313-9.
61. [61] Benter IF, Diz DI, Ferrario CM. α-Adrenergic and angiotensin II pressor responses are reduced in angiotensin-(1-7)-treated spontaneously hypertensive rats (abstract). Hypertension 1995;25:1416.
62. [62] Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol 1991;260:R1000-6.
63. [63] Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 1997;29:388-92.
64. [64] Tallant EA, Diz DI, Khosla MC, Ferrario CM. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension 1991;17:1135-43.
65. [65] Muthalif MM, Benter IF, Uddin MR, Harper JL, Malik KU. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharm Exp Ther 1998;284:388-98.
66. [66] Nickenig G, Geisen G, Vetter H, Sachinidis A. Characterization of angiotensin receptors on human skin fibroblasts. J Mol Med 1997;75:217-22.
67. [67] Santos RAS, Campagnole-Santos MJ, Baracho NCV, Fontes MAP, Silva LCS, Neves LAA, et al. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull 1994;35:293-398.